| Boronophenylalanine, a boron delivery agent for boron neutron capture therapy, is transported by ATB0,+, LAT1 and LAT2 P Wongthai, K Hagiwara, Y Miyoshi, P Wiriyasermkul, L Wei, R Ohgaki, ... Cancer Science 106 (3), 279-286, 2015 | 148 | 2015 |
| NPT1/SLC17A1 is a renal urate exporter in humans and its common gain‐of‐function variant decreases the risk of renal underexcretion gout T Chiba, H Matsuo, Y Kawamura, S Nagamori, T Nishiyama, L Wei, ... Arthritis & rheumatology 67 (1), 281-287, 2015 | 95 | 2015 |
| Interaction of the sodium/glucose cotransporter (SGLT) 2 inhibitor canagliflozin with SGLT1 and SGLT2: inhibition kinetics, sidedness of action, and transporter-associated … R Ohgaki, L Wei, K Yamada, T Hara, C Kuriyama, S Okuda, K Ueta, ... Journal of Pharmacology and Experimental Therapeutics 358 (1), 94-102, 2016 | 88 | 2016 |
| Amino acid transporter LAT1 in tumor-associated vascular endothelium promotes angiogenesis by regulating cell proliferation and VEGF-A-dependent mTORC1 activation L Quan, R Ohgaki, S Hara, S Okuda, L Wei, H Okanishi, S Nagamori, ... Journal of Experimental & Clinical Cancer Research 39, 1-17, 2020 | 47 | 2020 |
| Specific transport of 3‐fluoro‐l‐α‐methyl‐tyrosine by LAT1 explains its specificity to malignant tumors in imaging L Wei, H Tominaga, R Ohgaki, P Wiriyasermkul, K Hagiwara, S Okuda, ... Cancer Science 107 (3), 347-352, 2016 | 43 | 2016 |
| Boron delivery for boron neutron capture therapy targeting a cancer-upregulated oligopeptide transporter J Miyabe, R Ohgaki, K Saito, L Wei, L Quan, C Jin, X Liu, S Okuda, ... Journal of Pharmacological Sciences 139 (3), 215-222, 2019 | 30 | 2019 |
| Transport of 3-fluoro-l-α-methyl-tyrosine (FAMT) by organic ion transporters explains renal background in [18F] FAMT positron emission tomography L Wei, H Tominaga, R Ohgaki, P Wiriyasermkul, K Hagiwara, S Okuda, ... Journal of Pharmacological Sciences 130 (2), 101-109, 2016 | 14 | 2016 |
| Interaction of halogenated tyrosine/phenylalanine derivatives with organic anion transporter 1 in the renal handling of tumor imaging probes C Jin, L Wei, R Ohgaki, H Tominaga, M Xu, S Okuda, H Okanishi, ... Journal of Pharmacology and Experimental Therapeutics 375 (3), 451-462, 2020 | 7 | 2020 |
| NPT1/SLC17A1 is a renal urate exporter in humans and its common gain-of-function variant decreases the risk of renal underexcretion gout. Arthritis Rheumatol. 2015; 67: 281–7 T Chiba, H Matsuo, Y Kawamura, S Nagamori, T Nishiyama, L Wei | 5 | |
| Xiaobanxia decoction alleviates chemotherapy-induced nausea and vomiting by inhibiting GSDME-mediated pyroptosis X Liao, B Ye, W Hu, J Han, Y Zhao, Y Dai, X Wu, Z Mo, L Wei, K Nie Journal of Ethnopharmacology 318, 116970, 2024 | 2 | 2024 |
| Studies on the Incompatibility between Bulbus fritillariae and Radix aconiti praeparata Based on the P‐gp W Liu, L Wei, Y Kanai, X He Evidence‐Based Complementary and Alternative Medicine 2021 (1), 8351717, 2021 | 1 | 2021 |
| BPA-dipeptides, novel boron delivery agents for boron neutron capture therapy, are transported by oligopeptide transporter J Miyabe, R Ohgaki, K Saito, L Wei, S Okuda, S Nagamori, H Ohki, ... Proceedings for Annual Meeting of The Japanese Pharmacological Society …, 2018 | | 2018 |
| Structure-activity relations of aromatic amino acid derivatives to interact with organic anion transporter OAT1 reveal critical moieties for renal accumulation of imaging probes L Wei, R Ohgaki, H Tominaga, K Kaneda, S Okuda, S Nagamori, Y Kanai JOURNAL OF PHARMACOLOGICAL SCIENCES 133 (3), S100-S100, 2017 | | 2017 |
| Inhibition kinetics and inhibitory mechanism of the sodium/glucose cotransporter (SGLT) 2 inhibitor canagliflozin R Ohgaki, L Wei, K Yamada, T Hara, C Kuriyama, S Okuda, K Ueta, ... JOURNAL OF PHARMACOLOGICAL SCIENCES 133 (3), S231-S231, 2017 | | 2017 |
| Inhibition Kinetics, Sidedness of Action, and Transporter-mediated Uptake of the Sodium/Glucose Cotransporter (SGLT) 2 Inhibitor Canagliflozin: Implications for Its … R Ohgaki, L Wei, K Yamada, T Hara, C Kuriyama, S Okuda, K Ueta, ... DIABETES 65, A299-A299, 2016 | | 2016 |
| Molecular mechanism of renal accumulation of 3-fluoro-L-alpha-methyltyrosine (FAMT) in F-18-FAMT PET L Wei, H Tominaga, P Wiriyasermkul, R Ohgaki, K Hagiwara, S Okuda, ... JOURNAL OF PHARMACOLOGICAL SCIENCES 128 (3), S100-S100, 2015 | | 2015 |
| Kinetic analysis of 3F-L-alpha-amethyltyrosine (FAMT) transport by L-type amino acid transporter 1 L Wei, H Tominaga, P Wiriyasermkul, Y Nishinaka, R Ohgaki, K Tadagaki, ... JOURNAL OF PHARMACOLOGICAL SCIENCES 121, 125P-125P, 2013 | | 2013 |
